Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia (Q34108096)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

main subject

leukemia

1 reference

based on heuristic

inferred from title

tretinoin

1 reference

based on heuristic

inferred from title

author name string

Calleja EM

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

Warrell RP Jr

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

publication date

1 November 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

published in

Current Oncology Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

page(s)

519-523

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

cites work

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-000-0105-X

retrieved

21 January 2018

Medicinal arsenic and internal malignancies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-000-0105-X

retrieved

21 January 2018

Annexin II and bleeding in acute promyelocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic and cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia--clinical management of 15 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia in children

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia: a curable disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia: biology and treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All- trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia: from genetics to treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of childhood acute myelogenous leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia. New insights into diagnosis and therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11122887

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11912-000-0105-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

Dimensions Publication ID

1027169437

0 references

Fatcat ID

release_ezlltigy3bekrgi5n2qzcodsy4

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/ezlltigy3bekrgi5n2qzcodsy4

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

11122887

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11122887

retrieved

31 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34108096&oldid=2196258041"